NEW YORK, Dec. 30 (GenomeWeb News) - Six technology companies will develop software and applications for the pharmaceutical and healthcare industries using a digital signature standard developed by the SAFE-BioPharma Association, the organization said today.
The SAFE (Secure Access for Everyone) Vendor Partner Program encourages development of business applications, infrastructure, services and identity credentials, the association said. SAFE-BioPharma will test each application to guarantee it conforms to SAFE requirements.
Adobe, Arcot Systems, CoreStreet, nCipher, IBM, and Kyberpass are the first members of the program.
SAFE is expected to reduce medical research and drug development costs. The National Cancer Institute, US Food and Drug Administration, and the European Medicines Agency have committed to adopting the SAFE standard, the organization said.